Intellia Therapeutics CSO Laura Sepp-Lorenzino receives $1.8M in 2019
Intellia Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Intellia Therapeutics reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Intellia Therapeutics received on average a compensation package of $1M, a 73% decrease compared to previous year.
Average pay of disclosed executives at Intellia Therapeutics
Laura Sepp-Lorenzino, Chief Scientific Officer, received $1.8M in total. 75% of Sepp-Lorenzino's compensation, or $1.3M, was in option awards. Sepp-Lorenzino also received $204K in bonus, $239K in salary, as well as $221 in other compensation.
Andrew D. Schiermeier, Chief Operating Officer, received a compensation package of $1.2M, which decreased by 58% compared to previous year. 50% of the compensation package, or $612K, was in option awards.
John M. Leonard, Chief Executive Officer, earned $904K in 2019, a 91% decrease compared to previous year.
José E. Rivera, General Counsel, received $638K in 2019, which decreases by 76% compared to 2018.
Glenn G. Goddard, Chief Financial Officer, earned $542K in 2019, a 73% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2020.